JP Morgan Chase’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91K Hold
1,000
﹤0.01% 7024
2025
Q4
$2.71K Sell
1,000
-155,277
-99% -$510K ﹤0.01% 6894
2025
Q3
$661K Sell
156,277
-170,621
-52% -$750K ﹤0.01% 4860
2025
Q2
$1.63M Buy
326,898
+322,115
+6,735% +$1.4M ﹤0.01% 4062
2025
Q1
$21.1K Sell
4,783
-156,158
-97% -$733K ﹤0.01% 6135
2024
Q4
$748K Buy
160,941
+136,648
+562% +$751K ﹤0.01% 4815
2024
Q3
$169K Buy
24,293
+18,997
+359% +$149K ﹤0.01% 5484
2024
Q2
$41.3K Buy
5,296
+1,086
+26% +$8.04K ﹤0.01% 5933
2024
Q1
$29.9K Sell
4,210
-30,287
-88% -$200K ﹤0.01% 6116
2023
Q4
$231K Sell
34,497
-899
-3% -$5.06K ﹤0.01% 5307
2023
Q3
$199K Sell
35,396
-503,763
-93% -$3.36M ﹤0.01% 5076
2023
Q2
$2.98M Buy
539,159
+266,908
+98% +$1.44M ﹤0.01% 3256
2023
Q1
$1.7M Buy
272,251
+231,480
+568% +$1.29M ﹤0.01% 3648
2022
Q4
$189K Buy
40,771
+7,810
+24% +$38.5K ﹤0.01% 5060
2022
Q3
$154K Buy
32,961
+6,055
+23% +$38.2K ﹤0.01% 5070
2022
Q2
$159K Buy
26,906
+26,425
+5,494% +$294K ﹤0.01% 5183
2022
Q1
$9K Sell
481
-18
-4% -$413 ﹤0.01% 6224
2021
Q4
$17K Sell
499
-15,787
-97% -$635K ﹤0.01% 6253
2021
Q3
$668K Buy
16,286
+1,852
+13% +$67.2K ﹤0.01% 4559
2021
Q2
$520K Buy
14,434
+5,631
+64% +$208K ﹤0.01% 4669
2021
Q1
$343K Buy
8,803
+8,556
+3,464% +$385K ﹤0.01% 4893
2020
Q4
$10K Sell
247
-883,066
-100% -$40.6M ﹤0.01% 5389
2020
Q3
$49.5M Buy
+883,313
New +$46.8M 0.01% 976

Other funds holding GDRX

JP Morgan Chase's GDRX Position: Q1 2026 in Review

JP Morgan Chase held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 1,000 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #7024.

JP Morgan Chase first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $49.5M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • JP Morgan Chase held 1,000 shares of GoodRx Holdings worth $1.91K as of Q1 2026.
  • JP Morgan Chase left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7024 holding.
  • JP Morgan Chase first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's GoodRx Holdings position peaked at $49.5M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.